At the news
? NEUTRALIMPACT 1/10 6-K filed Sep 1, 2026 at 12:20 ET
AstraZeneca filed a routine 6-K notification of admission of 10,072 ordinary shares to trading on the London Stock Exchange, issued under the company's employee share schemes between 1 August 2026 and 31 August 2026. The total shares in issue post-admission is 1,551,043,461. This is a standard administrative filing with no material financial or operational impact, representing dilution of less than 0.001% of outstanding shares.
- 10,072 ordinary shares of $0.25 each were admitted to trading on the London Stock Exchange.
- Shares were issued under employee share schemes between 1 August 2026 and 31 August 2026.
- Total shares in issue after admission: 1,551,043,461.
- The new shares are fully fungible with existing ordinary shares.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access